Literature DB >> 15003182

New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus.

Chaim Putterman1.   

Abstract

Autoantibodies against double stranded (ds) DNA are not only a helpful serological marker for diagnosis of systemic lupus erythematosus (SLE), but have also been shown to be crucial in the pathogenesis of lupus nephritis. However, the question of how anti-dsDNA antibodies contribute to renal damage is unresolved. Many authorities believe that indirect binding (mediated by nuclear antigens) or direct cross-reactivity of anti-dsDNA antibodies with kidney antigens are important determinants of anti-dsDNA nephritogenicity. An alternative hypothesis for the renal pathogenicity of anti-dsDNA antibodies was proposed more than 20 years ago, namely that certain autoantibodies could penetrate into living cells and thus induce damage. Work from several laboratories has recently provided firm support for this iconoclastic theory, which contradicted prevailing immunologic dogma that cell interiors are inaccessible to antibodies. Here, we review the evidence that anti-dsDNA antibodies may penetrate into living cells, and discuss which intracellular events may follow from binding of anti-dsDNA antibodies to the cell surface and subsequent intracellular penetration. Determining the mechanism by which anti-dsDNA antibodies induce renal injury is important for understanding a major disease manifestation of lupus, and may lead to the development of novel approaches to the treatment of lupus renal disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003182     DOI: 10.1016/S1568-9972(03)00082-X

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  18 in total

1.  A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens.

Authors:  Y Xia; E Eryilmaz; E Der; R D Pawar; X Guo; D Cowburn; C Putterman
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

2.  CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.

Authors:  S Patschan; S Dolff; A Kribben; J Dürig; D Patschan; B Wilde; C Specker; T Philipp; O Witzke
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 3.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

4.  Elevated subclinical double-stranded DNA antibodies and future proliferative lupus nephritis.

Authors:  Stephen W Olson; Jessica J Lee; Lisa K Prince; Thomas P Baker; Patricia Papadopoulos; Jess Edison; Kevin C Abbott
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 8.237

5.  The SLE-key test serological signature: new insights into the course of lupus.

Authors:  Chaim Putterman; David S Pisetsky; Michelle Petri; Roberto Caricchio; Alan H B Wu; Ignacio Sanz; Jim C Oates; Steve Wallace; Rachel Sorek; Robert Gerwien; Pennina Safer; Keren Jakobi-Brook; Irun R Cohen
Journal:  Rheumatology (Oxford)       Date:  2018-09-01       Impact factor: 7.580

6.  The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies.

Authors:  Yumin Xia; Rahul D Pawar; Antonio S Nakouzi; Leal Herlitz; Anna Broder; Kui Liu; Beatrice Goilav; Manxia Fan; Ling Wang; Quan-Zhen Li; Arturo Casadevall; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-07-28       Impact factor: 7.094

7.  Generation of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases.

Authors:  Vera Gesheva; Zsuzsanna Szekeres; Nikolina Mihaylova; Iliyana Dimitrova; Maria Nikolova; Anna Erdei; Jozsef Prechl; Andrey Tchorbanov
Journal:  Hum Gene Ther Methods       Date:  2012-11-23       Impact factor: 2.396

Review 8.  IgM antibodies against dsDNA in SLE.

Authors:  Torsten Witte
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

9.  Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis.

Authors:  M Tucci; L Lombardi; H B Richards; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2008-09-15       Impact factor: 4.330

10.  Depression is an early disease manifestation in lupus-prone MRL/lpr mice.

Authors:  Hua-Xin Gao; Sean R Campbell; Min-Hui Cui; Pu Zong; Jong Hee-Hwang; Maria Gulinello; Chaim Putterman
Journal:  J Neuroimmunol       Date:  2009-01-03       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.